AAV9介導(dǎo)的CTRP9過(guò)表達(dá)對(duì)糖尿病大鼠心肌纖維化的抑制作用
[Abstract]:Aim: to investigate the effect and mechanism of AAV9-mediated CTRP9 overexpression on myocardial fibrosis in diabetic rats. Methods Forty-five 6-week-old healthy SD rats were divided into control group (GFP group) and CTRP9 group (n = 15). Each group was treated with streptozotocin (STZ) by intraperitoneal injection of streptozotocin (STZ). After 2 weeks of intraperitoneal injection of normal saline into the control group, AAV9 carrying GFP and CTRP9 genes was slowly injected into the tail vein of the GFP group and the CTRP9 group, respectively, and the control group was given normal saline with the same method. After 12 weeks of transfection, the levels of blood glucose and serum CTRP9 were detected, myocardial Masson staining and collagen volume fraction (CVF) were used to evaluate the degree of myocardial fibrosis in rats. The levels of mRNA and protein in the TGF- 尾 1/Smads pathway of three groups were detected by RT-PCR and Western blot, respectively. Results: after 12 weeks of transfection, compared with GFP group, serum CTRP9 increased and blood glucose decreased in CTRP9 group (P0.05), while the expression of TGF- 尾 1, Smad2 and Smad3 mRNA decreased significantly (P0.05), and the expression of 偽 -SMA-TGF- 尾 1 and p-Smad2/3 protein decreased (P0.05). Conclusion the overexpression of CTRP9 mediated by AAV9 may inhibit myocardial fibrosis in diabetic rats by regulating the TGF- 尾 1/Smads signaling pathway.
【作者單位】: 鄭州大學(xué)第二附屬醫(yī)院心血管內(nèi)科;鄭州大學(xué)第二附屬醫(yī)院急診科;
【基金】:河南省醫(yī)學(xué)科技攻關(guān)計(jì)劃項(xiàng)目201503094
【分類號(hào)】:R587.2
【相似文獻(xiàn)】
相關(guān)期刊論文 前4條
1 Naβenstein K;Breuckmann F;Huger M;楊岷;;對(duì)比增強(qiáng)MRI診斷系統(tǒng)性硬化患者心肌纖維化[J];放射學(xué)實(shí)踐;2009年05期
2 吳偉,張錦,邱陽(yáng);糖尿病心肌纖維化和肌動(dòng)蛋白異常表達(dá)的研究[J];中國(guó)組織化學(xué)與細(xì)胞化學(xué)雜志;2003年02期
3 楊瓊;吳永全;;內(nèi)質(zhì)網(wǎng)應(yīng)激與糖尿病心肌纖維化[J];心臟雜志;2014年01期
4 賈春澍;陳愛(ài)軍;李敏;李相軍;苗春生;李希寧;任立群;;硒和維生素E對(duì)克山病病區(qū)糧喂飼大鼠心肌纖維化的影響[J];吉林大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2011年02期
相關(guān)博士學(xué)位論文 前1條
1 鄧瑋;BMSC在微泡及BiAb輔助下修復(fù)心肌纖維化的實(shí)驗(yàn)研究及PⅢNP對(duì)冠心病合并代謝綜合征患者的預(yù)測(cè)價(jià)值[D];重慶醫(yī)科大學(xué);2011年
相關(guān)碩士學(xué)位論文 前4條
1 羅健;硫化氫可通過(guò)下調(diào)內(nèi)質(zhì)網(wǎng)應(yīng)激改善糖尿病大鼠的心肌纖維化[D];南華大學(xué);2015年
2 鄭杰;MicroRNA-223對(duì)糖尿病心肌纖維化EndMT的影響[D];山東大學(xué);2016年
3 趙華;內(nèi)皮素受體拮抗劑改善小鼠糖尿病心肌纖維化的分子機(jī)制研究[D];中國(guó)人民解放軍醫(yī)學(xué)院;2016年
4 段國(guó)宇;阿托伐他汀對(duì)百草枯致心肌纖維化和氧化應(yīng)激的影響[D];鄭州大學(xué);2013年
,本文編號(hào):2139327
本文鏈接:http://sikaile.net/yixuelunwen/nfm/2139327.html